Institutional Review Board, Hospital for Special Surgery
January 14, 2010
The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.
For further information, see Understanding Clinical Trials.
Howard J. Hillstrom, PhD
Sherry I. Backus, PT, DPT, MA
Andrew Kraszeski, MS
This study is looking to examine the effects that running on a banked surface has on running mechanics. The study will examine 20 female runners with a diagnosis of iliotibial band syndrome and 20 healthy female runners. All testing will be completed in one study visit that is expected to last 45 minutes. Testing will be conducted at the Leon Root, MD Motion Analysis Laboratory, 510 East 73rd Street, Ground Floor, New York, NY 10021.
Inclusion criteria for both the runners with ITBS and the runners serving as healthy controls are:
i. Female runners, ages 18 to 55 years
ii. Runners with ITBS, or a normal healthy runner
iii. Free of any other musculoskeletal or neuromuscular disorders
iv. Rearfoot striker
v. Running = 15 miles/week
vi. Able to run a 9 minute mile
vii. Able to read and understand English
viii. Diagnosis of ITBS must be made by a physician
ix. Self-reported comfort and experience with running on a treadmill
Exclusion criteria: Potential subjects will not be included in this study if they:
i. Do not meet the above-mentioned inclusion criteria
ii. Are pregnant
Jocelyn Hafer, MA